Kenya Hunter

Stay informed with Kenya Hunter’s coverage and analysis for Fortune.

Ozempic and Wegovy medications side by side

Ozempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity

By The Associated Press, Kenya Hunter, and others

Patient having a tomography exam.

Some cancer patients can find it hard to tell family and friends about their diagnosis: ‘You’re dealing with this all alone’

By Kenya Hunter and The Associated Press

Doses of the anti-viral drug Paxlovid are displayed in New York on Aug. 1, 2022. A study by Harvard researchers released on Jan. 26 found that Paxlovid was disproportionately given to patients with lower risk of severe infection. If it had been properly utilized, the authors concluded, more than 16,000 COVID-19 deaths could have been prevented.<br />
Stephanie Nano—AP Images

COVID antiviral Paxlovid could have saved more than 16,000 lives, had it been properly prescribed, new Harvard study finds

By Kenya Hunter and The Associated Press

Children's Defense Fund program director Graciela Camarena poses for a photo

31-year-old mom made 17 calls during pregnancy to get back onto Medicaid. She was reinstated in preterm labor on her hospital bed

By Amanda Seitz and Kenya Hunter

Syphilis

The number of babies born with syphilis is 10 times higher than a decade ago—and 32% higher than 2021

By Mike Stobbe, Kenya Hunter, and others

Man getting a shot

Nevada’s syphilis rate skyrockets 44% after debt ceiling deal suddenly slashes STD prevention budget

By Kenya Hunter and The Associated Press

Research shows that certain hair-straightening chemicals that have been used by Black women for years may increase the risk of uterine cancer.

FDA is considering a ban on certain hair-straightening chemicals: It would be a ‘win for public health—especially the health of Black women’

By Kenya Hunter and The Associated Press